ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2017

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.

Mirko V Sikirica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.